An efficient synthesis of uracil derivatives from 2-alkyl-Δ2-oxazolines and nitriles

Journal of Fluorine Chemistry

Volumn 129, Issue 9, 2008, Pages 836-847

  Fustero, Santos ^a,b   Sanz Cervera, Juan F ^a,b   Mérida, Salvador ^a   Román, Raquel ^a   Villanova, Salvador ^a   Ramírez de Arellano, Carmen ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

2 Oxazolines; Fluorinated enamino acid derivatives; Fluorinated compounds; Uracils

Indexed keywords

EID: 50549083470     PISSN: 00221139     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfluchem.2008.04.004     Document Type: Article

References (29)

1. In: Chu C.K., and Baker D.C. (Eds). Nucleosides and Nucleotides as Antitumor and Antiviral Agents (1993), Plenum Press, New York
2. Ozaki S. Med. Res. Rev. 16 (1996) 51-86
3. Ojima I., McCarthy J.R., and Welch J.T. Biomedical Frontiers of Fluorine Chemistry, ACS. Symp. Series vol. 639 (1996), American Chemical Society, Washington, DC
4. Filler R., and Kobayashi Y. Biomedicinal Aspects of Fluorine Chemistry (1982), Elsevier Biomedical Press, New York and Kodansha Ltd., Tokyo
5. Pankiewicz K.W. Carbohydr. Res. 327 (2000) 87-105
6. As examples, see:
7. Y. Tohyama, Y. Sanemitsu, Eur. Pat. Appl. EP 1,122,244 A1 (2001).
8. G. Theodoridis, S.D. Crawford, (FMC Corporation, USA) US 6,277,847 B1 (2001).
9. M.-W. Drewes, R. Andree, M. Dollinger, (Bayer A.-G., Germany) Ger. Offen. DE 19,632,005 A1 (1998).
10. T. Koiso, S. Ono, H. Kondo, T. Asada, (Dainippon Ink and Chemicals, Inc., Japan) Jpn. Kokai Tokkyo Koho JP 09,241,245 (1997).
11. V. Kameswaran, (American Cyanamid Co. USA) US 6,191,275 B1 (2001).
12. Yagi K., Akimoto K., Mimori N., Miyake T., Kudo M., Arai K., and Ishii S. Pest Manag. Sci. 56 (2000) 65-73
13. Fustero S., Piera J., Sanz-Cervera J.F., Catalán S., and Ramírez de Arellano C. Org. Lett. 6 (2004) 1417-1420
14. Fustero S., Catalán S., Flores S., Jiménez D., del Pozo C., Aceña J.L., Sanz-Cervera J.F., and Mérida S. QSAR Comb. Sci. 25 (2006) 753-760
15. Fustero S., Catalán S., Piera J., Sanz-Cervera J.F., Fernández B., and Aceña J.L. J. Org. Chem. 71 (2006) 4010-4013
16. Preliminary results were published as a communication; see:. Fustero S., Salavert E., Sanz-Cervera J.F., Piera J., and Asensio A. Chem. Commun. (2003) 844-845
17. Kamata K., Agata I., and Meyers A.I. J. Org. Chem. 63 (1998) 3113-3116
18. Kotoris C.C., Chen M.-J., and Taylor S. J. Org. Chem. 63 (1998) 8052-8057
19. Middleton W.J., and Bingham E.M. J. Org. Chem. 45 (1980) 2883-2887
20. ® (dimethoxyethylaminotrifluorosulfurane) were used at room temperature for 24 h instead of DAST. See:. Lal G.S., Pez G.P., Pesaresi R.J., Prozonic F.M., and Cheng H. J. Org. Chem. 64 (1999) 7048-7054
21. Fustero S., Díaz D., Asensio A., Navarro A., Kong J.S., and Aguilar E. Tetrahedron 55 (1999) 2695-2712
22. For a review see:. Cotarca L., Delogu P., Nardelli A., and Sunji V. Synthesis (1996) 553-576
23. Barluenga J., López-Ortiz J.F., and Gotor V.J. Chem. Soc., Perkin Trans. I (1983) 2273-2276
24. A similar behavior has been observed in related systems. See for example:. Brown G.R. J. Chem. Soc. Perkin Trans 1 (1973) 2022-2024
25. Lis R., Morgan T.K., Marisca A.J., Gómez R.P., Lind J.M., Davey D.D., Philips G.B., and Sullivan M.E. J. Med. Chem. 33 (1990) 2883-2891
26. Agami C., Dechoux L., Hamon L., and Melaimi M. J. Org. Chem. 65 (2000) 6666-6669 and references cited therein
27. Herndon J.L., Ismaiel A., Ingher P., Teitler M., and Glennon R.A. J. Med. Chem. 35 (1992) 4903-4910
28. It is noteworthy that compounds 16 in which Nu = Cl revert to a mixture 14 + 15 in proportions similar to those observed when they were obtained from 9 upon treatment with a base (i.e. aq. K2CO3/dioxane).
29. Noble S., Langtry H., and Lamb H.M. Drugs 55 (1998) 277-302